| Listed site | cdmo | cdmo |
|---|
| Summary | Full-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy manufacturing from preclinical to commercial scale, with bioreactor capacity up to 50,000L. | Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services. |
|---|
| Services | - Cell-Line Development
- Process Development
- CMC Analytical Development
- Formulation Development
- Stability Testing & Storage
- Quality Control Testing
- Upstream Processing
- Downstream Processing
- Recombinant Protein Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Microbial Fermentation
- Vaccine Manufacturing
- AAV Manufacturing
- Viral Vector Manufacturing
- Vial Filling
- Lyophilization (Freeze Drying)
- Prefilled Syringe (PFS) Filling
- Sterile Fill-Finish & Aseptic Manufacturing
- Technology Transfer
- CMC Regulatory Submission Support
- Analytical Method Development & Validation
- ICH Stability Studies
| - Cell-Line Development
- Process Development
- CMC Analytical Development
- Technology Transfer
- CMC Regulatory Submission Support
- Recombinant Protein Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- mRNA Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Quality Control Testing
- Biologics Development & Manufacturing
- Upstream Processing
- Downstream Processing
- Vial Filling
- Stability Testing & Storage
- Formulation Development
- Vaccine Manufacturing
- ADC Payload & Linker Synthesis
- Lipid Nanoparticle (LNP) Formulation
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Lyophilization (Freeze Drying)
|
|---|
| Modalities | - Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Peptide
- Vaccine
- AAV / Viral Vector Platform
| - Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- mRNA
- Vaccine
|
|---|
| Indications | Data not yet provided. | |
|---|
| Locations | - Southborough, Southborough, Massachusetts, United States
- Zhangjiang (P01), Shanghai, Shanghai, China
- Lingang (IP02), Shanghai, Shanghai, China
- Lingang (IP03), Shanghai, Shanghai, China
- Headquarters, Southborough, Massachusetts, United States
| - Bio Campus I, South Korea
- Bio Campus II, South Korea
- Headquarters / Bio Campus I, Incheon, Yeonsu-gu, Republic of Korea
- Bio Campus II, Incheon, Yeonsu-gu, Republic of Korea
- ADC Plant, Incheon, Yeonsu-gu, Republic of Korea
- Samsung Biologics America, United States
- Samsung Biologics Japan Office, Japan
- Headquarters
|
|---|
| Certifications | Data not yet provided. | Data not yet provided. |
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|